{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-149141","form_type":"8-K/A","ticker":"ELVN","cik":"0001672619","company_name":"Enliven Therapeutics, Inc.","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.516501+00:00","generated_at":"2026-06-01T07:42:19.339236+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Enliven Therapeutics appoints director Lori Kunkel to Nominating Committee","bullets":["Dr. Lori Kunkel appointed to Nominating and Corporate Governance Committee effective May 29, 2024.","Her board appointment was reported April 9, 2024; committee role now determined.","Appointment follows recommendation of the Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-149141","json":"https://secwatch.observer/filing/0001193125-24-149141.json","markdown":"https://secwatch.observer/filing/0001193125-24-149141.md","text":"https://secwatch.observer/filing/0001193125-24-149141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1672619/000119312524149141/0001193125-24-149141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1672619/000119312524149141/d816859d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:42:19.339236+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}